HK1136492A1 - Agent for promoting healing of living body - Google Patents

Agent for promoting healing of living body

Info

Publication number
HK1136492A1
HK1136492A1 HK10103308.9A HK10103308A HK1136492A1 HK 1136492 A1 HK1136492 A1 HK 1136492A1 HK 10103308 A HK10103308 A HK 10103308A HK 1136492 A1 HK1136492 A1 HK 1136492A1
Authority
HK
Hong Kong
Prior art keywords
living body
healing
acceleration
wound
culture solution
Prior art date
Application number
HK10103308.9A
Other languages
English (en)
Inventor
Naoyuki Moriya
Yukiko Moriya
Koji Kubota
Original Assignee
Aureo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aureo Co Ltd filed Critical Aureo Co Ltd
Publication of HK1136492A1 publication Critical patent/HK1136492A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK10103308.9A 2006-11-02 2010-03-30 Agent for promoting healing of living body HK1136492A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006298478 2006-11-02
PCT/JP2007/070523 WO2008053728A1 (fr) 2006-11-02 2007-10-22 Agent favorisant la guérison d'un organisme vivant

Publications (1)

Publication Number Publication Date
HK1136492A1 true HK1136492A1 (en) 2010-07-02

Family

ID=39344071

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10103308.9A HK1136492A1 (en) 2006-11-02 2010-03-30 Agent for promoting healing of living body

Country Status (8)

Country Link
US (2) US20100068184A1 (ja)
EP (2) EP2630961B1 (ja)
JP (2) JP5331482B2 (ja)
KR (1) KR20090080536A (ja)
CN (1) CN101626773B (ja)
HK (1) HK1136492A1 (ja)
TW (1) TWI364284B (ja)
WO (1) WO2008053728A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI496578B (zh) * 2009-10-08 2015-08-21 Aureo Co Ltd 流感病毒感染症的治療劑
EP2508190B1 (en) * 2009-12-03 2021-06-02 Aureo Co., Ltd. Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages
JP5554221B2 (ja) * 2010-12-13 2014-07-23 株式会社アウレオ ウシの***炎の予防・治療用組成物及びウシの***炎の予防・治療方法
WO2012147978A1 (ja) * 2011-04-28 2012-11-01 株式会社アウレオサイエンス 安定同位体２Ｈおよび／または安定同位体１３Ｃで標識されたβ－１，３－１，６グルカン、これを用いたプローブ、ならびにその製造方法
KR101225110B1 (ko) 2012-08-24 2013-01-25 재단법인 경북해양바이오산업연구원 오리오바시디움 플루란스 균주로부터 생성되는 신규한 생물학적 계면활성제
KR101978991B1 (ko) * 2017-02-07 2019-05-17 (주)모아캠 홍차 흑효모 발효물을 유효성분으로 포함하는 피부 항산화, 미백, 항노화용 화장료 조성물
KR20190058344A (ko) 2017-11-20 2019-05-29 (주)아모레퍼시픽 아우레오바시디움 풀루란스 균주의 배양물 또는 추출물을 포함하는 미세먼지에 의한 피부 손상 개선용 조성물
KR102645439B1 (ko) * 2018-11-09 2024-03-11 (주)아모레퍼시픽 아우레오바시디움 풀루란스 균주의 배양물 또는 추출물을 포함하는 저자극 피부 재생 또는 피부 진정용 조성물
CN111227049B (zh) * 2018-11-29 2022-08-12 内蒙古伊利实业集团股份有限公司 一种维持褐色植物基酸奶货架期内组织状态稳定性的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5461112A (en) * 1977-10-24 1979-05-17 Ono Pharmaceut Co Ltd Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component
JPS55113718A (en) * 1979-02-27 1980-09-02 Yakult Honsha Co Ltd Antitumor agent
JPS57149301A (en) 1981-03-11 1982-09-14 Daiichi Togyo Kk Novel polysaccharide having coagulating property
JPS62252730A (ja) * 1986-01-16 1987-11-04 Takeda Chem Ind Ltd 抗腫瘍剤
JPH0692441B2 (ja) * 1986-03-03 1994-11-16 株式会社林原生物化学研究所 β−Ｄ−グルカンとその製造方法及び用途
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
US5980918A (en) * 1997-10-24 1999-11-09 Brennen Medical, Inc. β-D-glucan topical composition
US6251877B1 (en) * 1998-03-24 2001-06-26 Pacific Corporation Composition for external application containing a β-1,6-branched-β-1,3-glucan
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2002204687A (ja) 2000-11-09 2002-07-23 Onaka Yasushi β−１．３−１．６グルカン（アウレオバシジウム培養液）の医療、保健、福祉、食品および各種産業分野での応用
JP3523220B2 (ja) * 2001-05-14 2004-04-26 一光化学株式会社 皮膚塗布剤
JP2003113097A (ja) * 2001-10-02 2003-04-18 Onaka Yasushi アウレオバシジウム培養液を含有する外用剤
JP4054697B2 (ja) * 2003-03-07 2008-02-27 株式会社アウレオ 便秘改善剤
EP1602377B1 (en) * 2003-03-07 2011-08-10 Aureo Co., Ltd. Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition
CN1244683C (zh) * 2003-11-21 2006-03-08 金华夏洋生物技术有限公司 短枝束孢霉菌
JP4268105B2 (ja) * 2004-09-09 2009-05-27 株式会社アウレオ β−グルカン含有組成物、その製造方法及び該組成物を含む飲食品若しくは皮膚用保湿剤
CN101031203B (zh) * 2004-09-24 2011-05-11 生物耐克斯特公司 抗一种或多种病原体的组合物的用途
JP4216268B2 (ja) * 2005-06-20 2009-01-28 株式会社タキザワ漢方廠 黒酵母菌の培養方法

Also Published As

Publication number Publication date
EP2630961A1 (en) 2013-08-28
US20100068184A1 (en) 2010-03-18
JP2013155203A (ja) 2013-08-15
CN101626773B (zh) 2013-04-17
JP5331482B2 (ja) 2013-10-30
CN101626773A (zh) 2010-01-13
KR20090080536A (ko) 2009-07-24
TW200826953A (en) 2008-07-01
EP2098240B1 (en) 2013-09-11
EP2098240A4 (en) 2010-11-03
JPWO2008053728A1 (ja) 2010-02-25
US20150297651A1 (en) 2015-10-22
EP2630961B1 (en) 2014-11-26
JP5715659B2 (ja) 2015-05-13
WO2008053728A1 (fr) 2008-05-08
TWI364284B (en) 2012-05-21
EP2098240A1 (en) 2009-09-09

Similar Documents

Publication Publication Date Title
HK1136492A1 (en) Agent for promoting healing of living body
Huang et al. Microenvironment‐based diabetic foot ulcer nanomedicine
EP3558399B1 (en) Multi-layer wound care product with perforated release layer
Patil et al. Fluorinated methacrylamide chitosan hydrogels enhance collagen synthesis in wound healing through increased oxygen availability
EP2548880A3 (en) Compositions for increasing telomerase activity
EP2422796A3 (en) Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
EP1792927A4 (en) NEW BLOCK COPOLYMER, MICELLA PREPARATION AND ANTICROPHIDE CONTAINING THIS AS ACTIVE INGREDIENTS
NZ606825A (en) Methods and compositions for treating complement-associated disorders
RU2013140182A (ru) Композиция гиалуроновой кислоты
NZ564399A (en) Liquid for preventing tissue adhesion and method of preventing tissue adhesion using trehalose
WO2009043031A3 (en) Microbubbles and methods for oxygen delivery
WO2008056368A3 (en) Use of ex-vivo cultured hematopoietic cells for treatment of peripheral vascular diseases
BRPI0507048A (pt) uso de baixa dosagem de eritropoetina para estimular células precursoras endoteliais, regenerar órgãos e retardar a progressão de danos em órgão alvo
EP2392322A3 (en) Dosing regimes for trans-clomiphene
WO2009134866A3 (en) Cell membrane engineering
WO2013100818A3 (en) A biocomposite for regeneration of injured tissue and organs, a kit for making the biocomposite, a method of making the biocomposite and a method of treating inquiries.
BR112013005673A2 (pt) uso de lipase de ácido lisossomal para tratamento de deficiência de lipase de ácido lisossomal em pacientes
WO2021174107A3 (en) Soluble ace2 variants and uses therefor
MX358492B (es) Suministro intraventricular lento.
WO2009134054A3 (en) Heparin-conjugated fibrin gel and method and kit for preparing the same
BR112012016128A8 (pt) Agente terapêutico (y-39983) para disfunção endotelial da córnea
Chen et al. Cerium oxide nanoparticles in wound care: a review of mechanisms and therapeutic applications
CN107929725A (zh) 一种环境友好型赖氨酸多肽护肤消毒液及其制备工艺
RU2414926C1 (ru) Гемостимулирующее средство и способ стимуляции гемопоэза
Ablove et al. Elevation in compartment pressure following hypovolemic shock and fluid resuscitation: a canine model